Radiation therapy in the treatment of cervical cancer: the University of Chicago/Michael Reese Hospital experience.
A retrospective analysis was conducted on 307 patients referred for radiation therapy at The University of Chicago and Michael Reese Hospital between 1971 and 1986. Median follow-up was 6.4 years. Treatment techniques varied during the time of the study. Actuarial disease-free survivals were 78%, 64%, 55%, 33%, 41%, and 60% for stage IB, IIA, IIB, IIIA, IIIB, and IVA, respectively. Stage, size of the cervical lesion, and hemoglobin level during treatment were prognostic factors. Treatment technique as well as time dose factors were analyzed with respect to survival, failures, and complications.
Rader
J S
JS
Department of Obstetrics of Gynecology, Michael Reese Hosptial, Chicago, Illinois.
Haraf
D J
DJ
Halpern
H J
HJ
Rotmensch
J
J
Spelbring
D R
DR
Sutton
H
H
Javaheri
G
G
Weichselbaum
R R
RR
D000328:Adult; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D007044:Hysterectomy; D015994:Incidence; D008875:Middle Aged; D009367:Neoplasm Staging; D011832:Radiation Injuries / Q000453:epidemiology; D011879:Radiotherapy Dosage; D012008:Recurrence; D012189:Retrospective Studies; D015996:Survival Rate; D002583:Uterine Cervical Neoplasms / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*
D006454:Hemoglobins